Skip to main content
Discovering the causes of cancer and the means of prevention

Staff Scientist in the Clinical Epidemiology Unit, Clinical Genetics Branch

The Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH) is recruiting a staff scientist in the Clinical Epidemiology Unit (CEU) of the Clinical Genetics Branch (CGB).  

The CEU/CGB is part of the Intramural Research Program of NCI.  The investigators in the Unit, among other duties, direct applied epidemiologic research that aims to develop and validate novel cancer screening and diagnostic methods, tied closely to a molecular epidemiologic understanding of cancer etiology and multi-stage carcinogenesis.  There is a longstanding interest in human papillomavirus (HPV) infection and cervical cancer.  At present, a Cancer Moonshot-funded initiative titled, “Accelerated Control of Cervical Cancer” is being conducted as part of the Unit’s responsibilities. This is a highly interdisciplinary, clinical effort to bring forward a set of novel, highly promising cervical screening methods adaptable to low- and high-resource settings. One combined screening strategy of particular interest is primary HPV testing of self- or clinician-collected cervical specimens, followed by deep-learning-based visual evaluation of cervical appearance to predict the risk that an HPV-infected patient has treatable precancer or early cancer. This approach would permit rapid, inexpensive, and accurate screening and treatment of precancerous lesions to prevent cervical cancer, even in low-resource settings.

The staff scientist, working under the direction of a senior investigator within the CGB, will have responsibilities for the field epidemiology aspects of several research studies of cervical screening, involving tens of thousands of participants in multiple clinical locations. Activities will include assisting with study design (developing protocols, questionnaires, choosing tools for screening and outpatient treatment of screen-positive women with cervical precancer, specimen and cervical imaging collection procedures), management (human subjects’ approvals, contracts and purchasing orders, data coding and cleaning, manipulating and harmonizing data from a variety of sources, specimens tracking, communication with national and international investigators to monitor study progress, organizing and coordinating meetings), basic statistical analysis, and preparation of reports for presentation or publication. Some international travel is required.

The successful candidate must hold an M.D. degree because of the clinical nature of the work (although a U.S. license is not required), and an M.P.H. or equivalent in epidemiology. Specific training and field-based experience with cervical screening is highly desirable. Knowledge of HPV epidemiology is desirable. The position requires proven organizational abilities, attention to detail, initiative, and an aptitude for multi-tasking. The ability to communicate effectively in speech and in writing is essential, as part of study coordination, but extensive publication history is not a requirement.

Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. NIH encourages the application and nomination of qualified women, minorities and individuals with disabilities. NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis. This position is subject to a background investigation.  Salary is commensurate with experience.

Interested individuals should send a cover letter, curriculum vitae, brief summary of research interests and experience, and two letters of reference to:

Nicolas Wentzensen, M.D., Ph.D., M.S.
Division of Cancer Epidemiology and Genetics, National Cancer Institute
9609 Medical Center Drive, Rm. 6E448 MSC 9774
Bethesda, MD 20892

Closing date for applications is January 18, 2020

DHHS, NIH, and NCI are Equal Opportunity Employers

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Staff Scientist in the Clinical Epidemiology Unit, Clinical Genetics Branch was originally published by the National Cancer Institute.”